Fact CheckerSign in

NCT07130968Enrolling by invitation

Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform

Source: ClinicalTrials.gov · Last updated 29 Apr 2026

Brief summary (registry, in English)

The goal of this observational study is to observe the characteristics of cardiopulmonary exercise testing (CPET) parameters in patients across different cardiovascular diseases and to evaluate the predictive value of multiparameter cardiopulmonary indices for 5-year major adverse cardiovascular events (MACE).

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
200000 (estimated)
First submitted
13 Aug 2025
Start date
1 Feb 2025
Primary completion date
30 Dec 2035
Lead sponsor
Guangdong Provincial People's Hospital
Diseases
Stroke
NCT number
NCT07130968

What you commit to

  • Study type: Observational
  • Planned participants: 200000
  • From 1 Feb 2025 to the primary completion date, 30 Dec 2035
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Comorbid severe conditions (e.g., recent acute myocardial infarction, unstable angina, uncontrolled arrhythmias, severe aortic coarctation or descending aortic aneurysm, acute myocarditis or pericarditis, acute congestive heart failure, acute respiratory failure, resting oxygen saturation \<93%, recent arterial or pulmonary embolism, pulmonary edema).
  • Conditions potentially exacerbated by exercise (e.g., acute cardiac insufficiency, exercise-induced asthma, epilepsy).
  • Physical disability due to musculoskeletal or neuromuscular disorders.

Other

  • Pregnancy or lactation.
  • Patients deemed unsuitable for participation by the investigator.

Who the study is looking for

  • Age: 18-80 years,
  • Ability to comprehend and provide written informed consent.

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Guangdong Provincial People's Hospital
Coordinator of this site? Confirm its status
GuangzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.